Get started
Author

Mark R. Stroud

Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci
2007 · Mandana Veiseh, Patrik Gabikian, et al. · Cancer Research · 418
Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Lea and sialosyl-Lex, and sulfated glycans modulate this binding
1991 · Kazuko Handa, Edward D. Nudelman, et al. · Biochemical and Biophysical Research Communications · 132
Cloning and Expression of the Histo-blood Group PkUDP-galactose:Galβ1–4Glcβ1-Cer α1,4-Galactosyltransferase
2000 · Rudi Steffensen, Karine Carlier, et al. · Journal of Biological Chemistry · 129
PDF
Further studies on cell adhesion based on Lex-Lex interaction, with new approaches: embryoglycan aggregation of F9 teratocarcinoma cells, and adhesion of various tumour cells based on Lex expression
1994 · Naoya Kojima, Bruce A. Fenderson, et al. · Glycoconjugate Journal · 123
Monosialogangliosides of Human Myelogenous Leukemia HL60 Cells and Normal Human Leukocytes. 2. Characterization of E-Selectin Binding Fractions, and Structural Requirements for Physiological Binding to E-Selectin
1996 · Mark R. Stroud, Kazuko Handa, et al. · Biochemistry · 110
Monoclonal antibodies directed to the blood group a associated structure, galactosyl-A: Specificity and relation to the thomsen-friedenreich antigen
1988 · Henrik Clausen, Mark Stroud, et al. · Molecular Immunology · 103
Chemical Re-engineering of Chlorotoxin Improves Bioconjugation Properties for Tumor Imaging and Targeted Therapy
2011 · Muharrem Akcan, Mark R. Stroud, et al. · Journal of Medicinal Chemistry · 90
Monosialogangliosides of Human Myelogenous Leukemia HL60 Cells and Normal Human Leukocytes. 1. Separation of E-Selectin Binding from Nonbinding Gangliosides, and Absence of Sialosyl-Lex Having Tetraosyl to Octaosyl Core
1996 · Mark R. Stroud, Kazuko Handa, et al. · Biochemistry · 88
Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2015 · Janean Fidel, Katie C. Kennedy, et al. · Cancer Research · 76
In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
2011 · Mark R. Stroud, Stacey J. Hansen, et al. · Current Pharmaceutical Design · 75
PDF
Monoclonal Antibody Directed to Ley Oligosaccharide Inhibits Implantation in the Mouse1
1995 · Zheng M. Zhu, Naoya Kojima, et al. · Biology of Reproduction · 74
Universal red blood cells—enzymatic conversion of blood group A and B antigens
2004 · Martin L Olsson, Cheryl A Hill, et al. · Transfusion Clinique et Biologique · 72
Sialosyl-Fucosyl Poly-LacNAc without the Sialosyl-LexEpitope as the Physiological Myeloid Cell Ligand in E-Selectin-Dependent Adhesion: Studies under Static and Dynamic Flow Conditions,
1997 · Kazuko Handa, Mark R. Stroud, et al. · Biochemistry · 69
Synthesis of carbocyclic analogs of guanosine 5'-(.beta.-L-fucopyranosyl diphosphate) (GDP-fucose) as potential inhibitors of fucosyltransferases.
1992 · Shaopei Cai, Mark R. Stroud, et al. · The Journal of Organic Chemistry · 67
The Drosophila Gene brainiac Encodes a Glycosyltransferase Putatively Involved in Glycosphingolipid Synthesis
2002 · Tilo Schwientek, Birgit Keck, et al. · Journal of Biological Chemistry · 60
Structural characterization of x2 glycosphingolipid, its extended form, and its sialosyl derivatives: accumulation associated with the rare blood group p phenotype
1992 · Jens J. Thorn, Steven B. Levery, et al. · Biochemistry · 43
The P Histo-Blood Group-Related Glycosphingolipid Sialosyl Galactosyl Globoside as a Preferred Binding Receptor for Uropathogenic Escherichia coli: Isolation and Structural Characterization from Human Kidney
1998 · Mark R. Stroud, Ann E. Stapleton, et al. · Biochemistry · 36
Extended type‐1 chain glycosphingolipid antigens
1992 · Mark R. STROUD, Steven B. LEVERY, et al. · European Journal of Biochemistry · 33
PDF
Human α1,3/4-Fucosyltransferases
1998 · Anne L. Sherwood, Anton T. Nguyen, et al. · Journal of Biological Chemistry · 29
Human Tumor-Associated Lea-Lex Hybrid Carbohydrate Antigen IV3(Gal.beta.1.fwdarw.3[Fuc.alpha.1.fwdarw.4]GlcNAc)III3FucnLc4 Defined by Monoclonal Antibody 43-9F: Enzymic Synthesis, Structural Characterization, and Comparative Reactivity with Various Antibodies
1994 · Mark R. Stroud, Steven B. Levery, et al. · Biochemistry · 29
Fucosylation of Complex Glycosphingolipids by Recombinant Fucosyltransferase-VII
1997 · Mark R. Stroud, Eric H. Holmes · Biochemical and Biophysical Research Communications · 15
Solid-phase synthesis and immunoreactivity of penta-O-(N-acetyl-α-D-galactosaminyl)-MUC1 eicosapeptide, a glycosylated counter part of the highly immunogenic tandem repeat sequence of carcinoma-associated mucin
1994 · François-Yves Dupradeau, Mark R. Stroud, et al. · Bioorganic & Medicinal Chemistry Letters · 9
A GDP-Fucose-Protected, Pyridoxal-5′-Phosphate/NaBH4-Sensitive Lys Residue Common to Human α1→3Fucosyltransferases Corresponds to Lys300 in FucT-IV
2000 · Anne L. Sherwood, William C. Davis, et al. · Biochemical and Biophysical Research Communications · 8
Differentiation of type 1 and type 2 chain linkages of native glycosphingolipids by positive‐ion fast‐atom bombardment mass spectrometry with collision‐induced dissociation and linked scanning
1991 · Mary Ellen K. Salyan, Mark R. Stroud, et al. · Rapid Communications in Mass Spectrometry · 7
Extended Type 1 Chain Glycosphingolipids
1993 · Mark R. Stroud, Steven B. Levery, et al. · ACS symposium series · 3
Works count: 43
Citation count: 1,903
H-index: 20
I10-index: 21
Year
Topic
Type